1 results match your criteria: "Australia (R.I.L.). canderson@georgeinstitute.org.au.[Affiliation]"
Stroke
May 2016
From the Neurology Department, Royal Prince Alfred Hospital, Sydney, Australia (C.D., L.D., C.S.A.); Neurological and Mental Health Division, The George Institute for Global Health, Sydney, New South Wales, Australia (H.A., S.S., X.W., J.C., E.H., R.I.L.); Department of Neurology, West China Hospital, Sichuan University, Chengdu, China (S.Z., M.L.); Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom (R.A.-S.S.); Division of Clinical Neurosciences, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Département de Neurosciences, Université de Montréal, Montréal, QC, Canada (C.S.); Department of Cardiovascular Sciences and NIHR Biomedical Research Unit in Cardiovascular Disease, University of Leicester, Leicester, United Kingdom (T.R.); Unidad de Neurología vascular, Servicio de Neurología, Departamento de Medicina, Clínica Alemana, Santiago, Chile (P.M.L.); Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago, Chile (P.M.L.); and Department of Medicine, Westmead Hospital Clinical School, Westmead, New South Wales, Australia (R.I.L.).
Background And Purpose: In patients with acute intracerebral hemorrhage (ICH), the shape and density of the hematoma are associated with its subsequent growth, but the impact of these parameters on clinical outcome is uncertain.
Methods: Baseline computed tomographic scans and clinical data were obtained in the Intensive Blood Pressure Reduction in Acute Intracerebral Hemorrhage Trial (INTERACT2). Three independent neurologists blind to clinical data assessed ICH for shape and density using a previously described scale.